Reliable, fast, and globally harmonized safety testing to keep your clinical trials on track – from study set-up through to data delivery.
Delivering that consistently across global, multi-site trials takes more than laboratory capacity. It requires the right balance of scientific expertise, operational infrastructure, and quality oversight to manage complexity without slowing your program down.
From first-in-human studies through post-marketing programs, we support your trial with integrated routine and safety testing built on harmonized processes, accredited laboratories, and experienced teams. By aligning testing strategy, sample handling, data delivery, and regulatory requirements, you can generate reliable results that stand up to scrutiny.
Our global laboratory network enables end-to-end execution, from protocol review and kit design through to sample collection, analysis, and electronic data transfer. Designed to scale with your study, this integrated approach delivers consistent results across regions, helping you identify risk earlier, safeguard patient well-being, and act with clarity at every stage of development.
Support your routine and safety testing with a fully integrated approach, from initial protocol review through to electronic data delivery. By connecting study setup, sample handling, testing, and reporting within harmonized workflows, your program runs consistently – no matter where your clinical sites are located.
Routine safety testing forms the foundation of effective patient monitoring across clinical trials, providing the data needed to assess safety and maintain study continuity at every phase.
We deliver fast, dependable results through standardized testing panels, with turnaround times of 24–48 hours depending on capability and geography, ensuring you have timely data to support clinical decisions.
Our large routine safety testing menu includes:
Reliable sample management is fundamental to data quality. We design and deliver customized kit solutions, coordinate transport logistics, and manage sample receipt and processing with full traceability from collection through testing.
Our sample management services include:
Shipment coordination to analytical laboratories for specialty testing.
We deliver results in formats that fit your study infrastructure. The reporting format and content are agreed at study set-up, and all data is accessible through Cerba Trova, our secure, 21 CFR Part 11-compliant online portal – with real-time updates every 30 minutes.
Our reporting capabilities include:
From protocol review through sample collection, testing, and data delivery, each stage of our workflow is designed to maintain sample integrity, minimize variability, and ensure reliable safety data across global clinical trials.
*depending on safety testing capability and geographical location.
Our global laboratory network delivers routine and safety testing with harmonized standard operating procedures (SOPs), shared quality frameworks, and consistent turnaround times – wherever your clinical sites are located.
Belgium
South Africa
United States
Canada
China
Taiwan
Australia
Japan
For trials combining routine safety testing with specialty assays, we provide integrated laboratory solutions using validated, state-of-the-art platforms, all under a single quality framework.
High-parameter flow cytometry
AI-driven analytics for flow cytometry
Next-generation sequencing (NGS)
Spatial imaging
Digital pathology and image analysis
Sample collection and preservation systems
Nucleic acid extraction and preparation kits
In situ hybridization and cytogenetics techniques
Immunoassays
Cellular immune response assays
Manage global sample logistics with coordinated transport, tracking, and oversight to ensure timely delivery and maintain sample integrity throughout your study.
Support study execution with customized kit design, assembly, and distribution, ensuring accurate collection and consistency across all clinical sites.
Support safety assessment with bioanalytical testing, including immunogenicity and pharmacokinetics, enabling reliable evaluation of biological drug exposure and immune response.
Enable sensitive biomarker and safety testing with immunoassays, supporting immune monitoring, protein quantification, and clinically relevant data generation.
Enhance safety and immune monitoring with flow cytometry, enabling detailed cellular analysis to support complex clinical trial endpoints and decision-making.
Learn how integrated testing strategies support patient monitoring and safety assessment in CAR-T clinical trials across complex treatment pathways.